Added to YB: 2019-03-01
Pitch date: 2019-03-01
ALEC:US [bullish]
Alector, Inc.
-93.13%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.
Market Cap
$135.3M
Pitch Price
$21.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.12
P/E
-1.15
EV/Sales
-1.71
Sector
Biotechnology
Category
N/A
Show full summary:
ALECTOR INC COM ALEC:US
A summary for this pitch has not been created yet.
Read full article (0 min)